Entity,Identifier
cardiometabolic syndrome,CoDiet_A0_1
cardiometabolic syndromes,CoDiet_A0_2
insulin resistance syndrome,CoDiet_A0_3
metabolic cardiovascular syndrome,CoDiet_A0_4
metabolic syndrome,MESH:D024821
MetS,MESH:D024821
syndrome X,MESH:D024821
fasting insulin,CoDiet_A1_1
HOMA-IR,CoDiet_A1_2
lowered insulin sensitivity,CoDiet_A1_3
insulin resistance,MESH:D003924
insulin resistant,CoDiet_A1_5
insulin sensitivity,CoDiet_A1_6
insulin tolerance,CoDiet_A1_7
abdominal girth,CoDiet_A2_1
abdominal obesity,CoDiet_A2_2
anthropometry,CoDiet_A2_3
body composition,CoDiet_A2_4
body fat distribution,CoDiet_A2_5
Body Mass Index,CoDiet_A2_6
BMI,CoDiet_A2_7
body weight,CoDiet_A2_8
body weight reduction,CoDiet_A2_9
central fat distribution,CoDiet_A2_10
central obesity,CoDiet_A2_11
elevated waist circumference,CoDiet_A2_12
fat mass,CoDiet_A2_13
fat mass percentage,CoDiet_A2_14
high body mass index,CoDiet_A2_15
increase in body mass index,CoDiet_A2_16
obese,MESH:D009765
obesity,MESH:D009765
overweight,CoDiet_A2_19
reduce body weight,CoDiet_A2_20
skinfold thickness,CoDiet_A2_21
trunk fat percentage,CoDiet_A2_22
visceral fat,CoDiet_A2_23
waist-hip ratio,CoDiet_A2_24
waist-to-hip ratio,CoDiet_A2_25
waist circumference,CoDiet_A2_26
waist circumferences,CoDiet_A2_27
WC,CoDiet_A2_28
weight control,CoDiet_A2_29
weight gain,CoDiet_A2_30
weight loss,CoDiet_A2_31
weight maintenance,CoDiet_A2_32
weight reduction,CoDiet_A2_33
altered lipoproteins,CoDiet_A3_1
cholesterol efflux,CoDiet_A3_2
dislipidemia,MESH:D008052
dyslipidemia,MESH:D008052
dyslipidaemia,MESH:D008052
dyslipoproteinemia,MESH:D007009
dyslipoproteinaemia,MESH:D007009
elevated blood lipids,CoDiet_A3_8
elevated cholesterol,CoDiet_A3_9
elevated triglycerides,CoDiet_A3_10
HDL-cholesterol,CoDiet_A3_11
HDL cholesterol,CoDiet_A3_12
HDL-C,CoDiet_A3_13
high cholesterol,CoDiet_A3_14
high triglycerides,CoDiet_A3_15
hypercholesterolemia,CoDiet_A3_16
hyperlipidemia,CoDiet_A3_17
hyperlipidaemia,CoDiet_A3_18
hyperlipoproteinemia,CoDiet_A3_19
hypertriglyceridemia,CoDiet_A3_20
LDL-C,CoDiet_A3_21
lipid abnormalities,CoDiet_A3_22
lipid homeostasis,CoDiet_A3_23
lipids,CoDiet_A3_24
raised plasma lipids,CoDiet_A3_25
reduced HDL-C,CoDiet_A3_26
triacylglycerol,CoDiet_A3_27
triglyceride,CoDiet_A3_28
triglycerides,CoDiet_A3_29
TG,CoDiet_A3_30
VLDL cholesterol,CoDiet_A3_31
blood pressure,CoDiet_A4_1
elevated blood pressure,CoDiet_A4_2
elevated BP,CoDiet_A4_3
high blood pressure,CoDiet_A4_4
hypertension,MESH:D006973
increased blood pressure,CoDiet_A4_6
prehypertension,CoDiet_A4_7
raised blood pressure,CoDiet_A4_8
reduce blood pressure,CoDiet_A4_9
abnormal glucose,CoDiet_A5_1
blood glucose,CoDiet_A5_2
dysglycemia,CoDiet_A5_3
dysglycaemia,CoDiet_A5_4
elevated fasting glucose,CoDiet_A5_5
fasting blood glucose,CoDiet_A5_6
fasting glucose,CoDiet_A5_7
fasting plasma glucose,CoDiet_A5_8
glucose metabolism,CoDiet_A5_9
glucose response,CoDiet_A5_10
glycaemia,CoDiet_A5_11
glycemia,CoDiet_A5_12
glycemic control,CoDiet_A5_13
glycaemic control,CoDiet_A5_14
glycaemic response,CoDiet_A5_15
glycemic response,CoDiet_A5_16
glycated haemoglobin,CoDiet_A5_17
glycated hemoglobin,CoDiet_A5_18
haemoglobin A1C,CoDiet_A5_19
hemoglobin A1C,CoDiet_A5_20
HbA1C,CoDiet_A5_21
hyperglycaemia,MESH:D006943
hyperglycemia,MESH:D006943
impaired fasting glucose,CoDiet_A5_24
IFG,CoDiet_A5_25
impaired glucose,CoDiet_A5_26
impaired glucose disposal,CoDiet_A5_27
impaired glucose tolerance,CoDiet_A5_28
IGT,CoDiet_A5_29
increased blood glucose,CoDiet_A5_30
oral glucose tolerance test,CoDiet_A5_31
OGTT,CoDiet_A5_32
raised plasma glucose,CoDiet_A5_33
microalbuminuria,CoDiet_A6_1
diabetes,MESH:D003920
diabetes mellitus,MESH:D003920
DM,MESH:D003920
T2D,MESH:D003924
T2DM,MESH:D003924
type 2 diabetes,MESH:D003924
type 2 diabetes mellitus,MESH:D003924
type II diabetes,MESH:D003924
type II diabetes mellitus,MESH:D003924
acute coronary syndromes,CoDiet_R2_1
arterial elasticity,CoDiet_R2_2
arterial stiffening,CoDiet_R2_3
arterial stiffness,CoDiet_R2_4
arteriosclerosis,MESH:D001161
atherosclerotic cardiovascular disease,MESH:D050197
ASCVD,CoDiet_R2_7
atherogenesis,CoDiet_R2_8
atherogeneses,CoDiet_R2_9
atherosclerosis,MESH:D001161
atherosclerotic disease,MESH:D001161
atherogenic dyslipidemia,CoDiet_R2_12
atherosclerosis,MESH:D001161
atherosclerotic risk,CoDiet_R2_14
cardiac artery disease,CoDiet_R2_15
cardiac disease,CoDiet_R2_16
cardiac event,CoDiet_R2_17
cardiometabolic disease,CoDiet_R2_18
cardiometabolic diseases,CoDiet_R2_19
cardiovascular diseases,CoDiet_R2_20
carotid intimal-medial thickness,CoDiet_R2_21
congestive heart failure,MESH:D006333
coronary arteriosclerosis,MESH:D003324
coronary atherosclerosis,MESH:D003324
coronary artery disease,MESH:D003324
coronary calcium,CoDiet_R2_26
coronary heart disease,MESH:D003327
coronary vascular disease,CoDiet_R2_28
heart attack,MESH:D009203
heart attacks,MESH:D009203
heart disease,CoDiet_R2_30
left main disease,CoDiet_R2_31
left main coronary disease,CoDiet_R2_32
myocardial infarction,MESH:D009203
primary cardiac arrest,MESH:D006323
sudden cardiac death,CoDiet_R2_35
visceral adipose disease,CoDiet_R2_36
carotid artery disease,MESH:D002340
carotid stenosis,MESH:D016893
cerebrovascular disorder,MESH:D002561
stroke,MESH:D002561
TIA,MESH:D002546
transient ischemic attack,MESH:D002546
alcoholic fatty liver,MESH:D005235
liver steatosis,MESH:D005234
non-alcoholic fatty liver disease,MESH:D065626
steatohepatitis,obo:DOID_0080547 
steatosis,MESH:D005234
visceral steatosis,MESH:D005234
polycystic ovary syndrome,MESH:D011085
PCOS,MESH:D011085
cholesterol gallstones,CoDiet_R6_1
gallstones,CoDiet_R6_2
apnea,MESH:D012891
apnoea,MESH:D012891
sleep apnoea,MESH:D012891
lipodystrophy,MESH:D008060
acidosis,obo:DOID_0050758
chronic renal disease,MESH:D007676
diabetic nephropathy,CoDiet_R9_3
diabetic kidney disease,CoDiet_R9_4
end-stage renal disease,obo:DOID_783
reduced glomerular filtration rate,CoDiet_R9_6
abdominal obesity-metabolic syndrome,MESH:C535554
dysmetabolic syndrome X,MESH:D024821
metabolic syndrome X,MESH:D024821
abdominal obesity-metabolic syndrome 1,MESH:D024821
noninsulin-dependent diabetes mellitus,MESH:D003924
non-insulin-dependent diabetes mellitus,MESH:D003924
NIDDM,MESH:D003924
lipoatrophic diabetes,MESH:D003923
lipoatrophic diabetes mellitus,MESH:D003923
NAFLD,MESH:D065626
non-alcoholic steatohepatitis,obo:DOID_0080547
hepatic lipidosis,MESH:D005234
Steatosis of liver,MESH:D005234
fatty liver disease,MESH:D005234
NASH,obo:DOID_0080547 
Alcoholic Steatohepatitis,MESH:D005235
lipid metabolism disorder,MESH:D008052
fatty acid metabolism disorder,MESH:D008052
cardiopulmonary arrest,MESH:D006323
circulatory arrest,MESH:D006323
cardiac arrest,MESH:D006323
cerebrovascular disease,MESH:D002561
transient cerebral ischemia,MESH:D002546
transient ischemic attack,MESH:D002546
transient ischemic attacks,MESH:D002546
chronic kidney disease,MESH:D007676
chronic kidney failure,MESH:D007676
chronic renal failure syndrome,MESH:D007676
end-stage kidney disease,obo:DOID_783
end stage renal disease,obo:DOID_783
end stage kidney disease,obo:DOID_783
